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Continuous contact with self-major histocompatibility complex (MHC) ligands is essential for
survival of naı¨ve T cells but not memory cells. This surprising ﬁnding implies that T cell
subsets may vary in their relative T-cell receptor (TCR) sensitivity. Here we show that in
CD8þT cells TCR sensitivity correlates inversely with levels of CD5, a marker for strong
self-MHC reactivity. We also show that TCR sensitivity is lower in memory CD8þ Tcells than
naı¨ve cells. In both situations, TCR hypo-responsiveness applies only to short-term TCR
signalling events and not to proliferation, and correlates directly with increased expression of
a phosphatase, CD45 and reciprocal decreased expression of activated LCK. Inhibition by high
CD45 on CD8þ T cells may protect against overt TCR auto-MHC reactivity, while enhanced
sensitivity to cytokines ensures strong responses to foreign antigens.
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D
ifferentiation of naı¨ve T cells into memory cells leads to
enhanced responses to foreign antigens with retention of
tolerance to self-antigens1,2. For naı¨ve T cells, self-tolerance
is established in the thymus through negative selection of cells
with strong reactivity for self-peptide/major histocompatibility
complexes (MHCs) (self-pMHC) plus positive selection of cells
with low but signiﬁcant afﬁnity for self-pMHC (ref. 3). Especially
for CD8þ cells, naı¨ve T-cell recognition of self-pMHC ligands in
the extra-thymic environment is essential for cell survival: such
recognition elicits low-level TCR signals which, together with IL-7,
upregulate Bcl-2 and promote long-term survival of naı¨ve CD8þ T
cells in interphase4,5.
Since naı¨ve T cells undergoing positive selection in the thymus
are presumed to vary in their degree of self-pMHC reactivity, cells
with the highest afﬁnity (just below the level leading to negative
selection) would be potentially dangerous in the post-thymic
environment. Because of this problem, positively selected T cells
are subjected to a process of mild TCR desensitisation before
leaving the thymus6,7. Such TCR ‘‘tuning’’ occurs during the
differentiation of mature CD4þ and CD8þ single-positive (SP)
cells from CD4þCD8þ double-positive (DP) precursors and is
associated with upregulation of negative regulators of TCR
signalling, notably CD5, and downregulation of microRNA
(miR)-181a which inhibits expression of negative regulatory
protein tyrosine phosphatases (PTPs)8,9. Although TCR tuning is
presumed to reduce reactivity to self-pMHC ligands and thereby
promote self-tolerance, direct support for this notion is sparse.
The relevant question here is whether mature T cells with high
innate self-pMHC reactivity, for example, naı¨ve T cells with high
expression of CD5 (CD5hi cells), show lower TCR sensitivity than
CD5lo cells. In fact, there is evidence against this idea. Thus,
for naı¨ve T cells, CD5hi cells show higher background expression
of tyrosine-phosphorylated CD3z than CD5lo cells10,11.
Also, CD5hi cells display stronger lymphopenia-driven
homeostatic proliferation (HP) as well as antigen-speciﬁc
expansion than CD5lo cells10,12,13. These ﬁndings are not easy
to reconcile with the notion that self-reactivity is regulated by
TCR tuning, at least as deﬁned by relative CD5 expression.
Although continuous contact with self-pMHC ligands is
essential for naı¨ve CD8þ T cells, memory CD8þ T cells can
survive in the absence of these ligands14. This ﬁnding is
surprising because the enhanced expression of adhesion
molecules on memory cells would be expected to augment
contact with self-pMHC, especially on antigen-presenting cells
(APC). One explanation for this ﬁnding is that differentiation of
naı¨ve into memory CD8þ T cells reduces their TCR sensitivity.
This idea seems unlikely because memory CD8þ T cells generally
give enhanced proliferative responses to antigen15–17. However,
this is not invariably the case. Thus, as deﬁned by
phosphorylation (p) of ERK after contact with speciﬁc antigen,
TCR sensitivity of naı¨ve and memory CD8þ T cells was reported
to be indistinguishable18. Moreover, a recent study found reduced
TCR sensitivity of memory CD8þ T cells relative to naı¨ve cells
for p-ZAP-70 induction19. Like two others20,21, this study also
reported that memory CD8þ T cells gave lower proliferative
responses to antigen than naı¨ve CD8þ T cells. By contrast, many
other studies found that memory CD8þ T cells gave better
proliferative response than naı¨ve cells15,16,22.
In this paper, we sought evidence of TCR tuning in mature
CD8þ T cells by multiple parameters, ﬁrst in CD5lo versus CD5hi
subsets of naı¨ve cells, and then in naı¨ve versus memory cells.
For naı¨ve CD8þ T cells, the results show that CD5hi cells are less
TCR sensitive than CD5lo cells but are more sensitive to
cytokines. Likewise, memory CD8þ T cells have lower TCR
sensitivity than naı¨ve cells but increased sensitivity to cytokines,
accounting for their increased responsiveness to antigen. In each
situation, TCR sensitivity correlates inversely with cell-surface
density of CD45.
Results
Proliferation versus TCR signalling in naı¨ve CD8þ T-cell subsets.
In initial experiments, FACS-sorted CD5lo and CD5hi subsets of
naı¨ve CD44lo CD8þ T cells (Supplementary Fig. 1a) were
analysed for expression of tyrosine-phosphorylated CD3z
(p-CD3z). In agreement with prior studies on naı¨ve T cells10,11,
CD5hi CD44lo CD8þ T cells prepared from young C57BL/6 (B6)
mice showed higher background expression of p-CD3z than
CD5lo cells (Fig. 1a). Likewise, as for HP in lymphopenic hosts12,
CD5hi cells displayed more extensive proliferation (CFSE
dilution) than CD5lo cells when cultured with cross-linked
anti-CD3 monoclonal antibody (Cx-aCD3 mAb) in vitro
(Fig. 1b). Collectively, these data would seem to argue against
the concept of TCR tuning of mature T cells. However, for resting
T cells, phosphorylation of CD3z is only partial and is therefore
not necessarily indicative of TCR signalling23. Also, as shown
elsewhere12, stronger proliferation of CD5hi than CD5lo CD8þ
T cells following CD3 ligation may simply reﬂect the enhanced
sensitivity of CD5hi cells to cytokines, including endogenous IL-2
(Fig. 1b). Indeed, CD3 mAb-induced proliferation of both subsets
was minimal following IL-2 blockade or with IL-2-deﬁcient naı¨ve
CD8þ T cells (Supplementary Fig. 1b,c).
To examine the inﬂuence of CD5 expression on downstream
TCR signalling, puriﬁed naı¨ve (CD44lo) populations of CD5hi and
CD5lo CD8þ T cells were cultured with soluble anti-CD3
(S-aCD3) mAb to examine phosphorylation of ERK (p-ERK) and
other signalling molecules by immunoblot analysis. Here, the
striking ﬁnding was that induction of p-ERK, p-PLCg and
p-ZAP-70 after brief (2–15min) exposure to S-aCD3 mAb
was clearly more prominent in CD5lo cells than in CD5hi
cells (Fig. 1c–e). Similar ﬁndings applied following culture with
strongly stimulatory Cx-aCD3 mAb (Fig. 1f,g and Supplementary
Fig. 1d); note that, unlike Cx-aCD3, culture with S-aCD3 failed
to cause T-cell activation (Supplementary Fig. 1e) and is therefore
more relevant to the weak TCR signalling induced when CD8þ
T cells encounter self-pMHC ligands under in vivo conditions.
The poor induction of p-ERK by CD5hi CD8þ T cells after
CD3 ligation was not seen following culture with phorbol
myristate acetate (PMA)±ionomycin (Supplementary Fig. 1f),
indicating no intrinsic signalling defect, and could not be
overcome by addition of IL-2, despite strong induction of
p-STAT5 in these cells (Fig. 1h). As for polyclonal CD8þ T
cells, the inverse correlation between CD5 expression and p-ERK
induction applied to TCR transgenic (Tg) mice. Thus, for CD8þ
T cells from TCR Tg lines with high CD5 expression, namely
OT-1 and 2C, these cells showed much weaker p-ERK induction
after CD3 ligation than CD8þ T cells from the HY line where the
clonotype-positive cells are all CD5lo cells (Fig. 1i, upper); by
contrast, the minor component of HY CD5hi cells with
endogenous TCR showed much weaker p-ERK (Fig. 1i, lower).
Similar ﬁndings were applied to CD69 upregulation. Thus, as for
p-ERK induction, HY CD8þ T cells showed much higher CD69
upregulation at 3 h after CD3 ligation than OT-1 CD8þ T cells
(Supplementary Fig. 1g); note that, relative to p-ERK induction,
CD69 induction was slow, being very low at 1 h.
The above ﬁndings indicated that, in marked contrast to
p-CD3z expression and proliferative responses, naı¨ve CD5hi
CD8þ T cells showed weaker downstream TCR signalling than
CD5lo cells. As discussed later, CD5hi naı¨ve CD8þ T cells also
showed a reduced Ca2þ ﬂux following CD3 ligation and, notably,
reduced constitutive expression of p-LCK relative to CD5lo cells
(see below).
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TCR sensitivity of naı¨ve versus memory CD8þ T cells. The
implication from the above data is that naı¨ve T cells with ‘‘above-
average’’ afﬁnity for self-components undergo a form of TCR
desensitisation that prevents the cells from displaying overt auto-
reactivity; perhaps because these cells have enhanced sensitivity to
IL-2, the cells do not show diminished responses to foreign
antigens but rather exhibit enhanced responses10,13. What
then happens to TCR reactivity when naı¨ve T cells switch to
memory cells?
As mentioned earlier, memory T cells generally give stronger
and more rapid responses to foreign antigens than naı¨ve
T cells15,16,22. In support of this dogma, CD8þ T cells with a
memory (CD44hi) phenotype (MP) prepared from B6 mice
(Supplementary Fig. 2a) gave far stronger proliferative responses
(CFSE dilution) to Cx-aCD3 than naı¨ve CD44lo CD8þ T cells
(Fig. 2a). However, CD44hi MP cells are known to secrete more
IL-2 (Supplementary Fig. 2b) and display a higher density of
IL-2Rb (CD122) than naı¨ve cells (Supplementary Fig. 2c). Hence,
better responses of MP cells to antigen could reﬂect heightened
cytokine responsiveness to endogenous IL-2 (Supplementary
Fig. 2d). If so, the relevant question is whether MP cells show
altered early TCR responsiveness. Here, the striking ﬁnding was
that, following culture with either S-aCD3 (Fig. 2b–g) or
Cx-aCD3 (Fig. 2b,f,h), MP CD44hi CD8þ T cells showed
much weaker p-ERK and also p-ZAP-70 induction than naı¨ve
CD44lo CD8þ T cells; for p-ERK, weaker induction in CD44hi
than CD44lo cells also applied for ﬂow cytometry via intracellular
staining with p-ERK mAb (Supplementary Fig. 2e–g) and was in
accord with decreased upregulation of CD69 expression in
CD44hi cells (Supplementary Fig. 2h). Likewise, induction of a
Ca2þ ﬂux after exposure to Cx-aCD3 was far lower for CD44hi
CD8þ T cells than for CD44lo cells (Fig. 2i, upper); for the latter,
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Figure 1 | TCR sensitivity of CD5lo versus CD5hi naı¨ve CD8þ T cells. (a) Levels of tyrosine-phosphorylated CD3z chain (p-CD3z; 21 kDa) in freshly
isolated CD5lo and CD5hi B6 naı¨ve (CD44lo) CD8þ T cells (relative to b-actin; mean±s.d.). (b) Proliferation of CFSE-labelled CD5lo and CD5hi B6 naı¨ve
CD8þ T cells after incubation with IL-2, IL-7, or cross-linked anti-CD3 (Cx-aCD3) mAb. (c–e) ERK phosphorylation (c) and densitometric levels (relative
to total ERK; d or b-actin; e) of phosphorylated ERK (d,e), ZAP-70 (e), PLCg (e), and AKT (e) in CD5lo and CD5hi B6 naı¨ve CD8þ Tcells after incubation
with soluble anti-CD3 (S-aCD3) mAb (graphs in d and e show mean±s.d.). (f,g) Phosphorylation of ERK and ZAP70 (f) and levels of phosphorylated
ZAP-70, PLCg, ERK and AKT (relative to b-actin; mean±s.d.) (g) in CD5lo and CD5hi B6 naı¨ve CD8þ T cells after incubation with Cx-aCD3 mAb.
(h) Phosphorylation of ERK and STAT5 in CD5lo and CD5hi B6 naı¨ve CD8þ Tcells after S-aCD3 mAb incubation with or without IL-2. (i) CD5 levels by ﬂow
cytometry (top left) and S-aCD3 mAb-induced ERK phosphorylation by Western blot (top right) in naı¨ve CD8þ Tcells from HY, 2C and OT-I TCR Tg mice
(top and bottom) or CD5lo and CD5hi naı¨ve CD8þ Tcells from B6 and HYmice (bottom); note that CD5hi HY cells are TCR-clonotype negative. Data are
representative of at least four (a,c-g) and three independent experiments (b,h,i). Unpaired Student’s t-test was used for the statistical analysis. *Po0.05;
**Po0.005; ***Po0.0005.
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consistent with the above data on p-ERK induction (Fig. 1c–h),
CD44lo CD5lo cells showed higher Ca2þ ﬂuxes than CD5hi cells
(Fig. 2i, lower and Supplementary Fig. 2i). Consistent with the
role of PLCg in Ca2þ signalling24, the limited Ca2þ ﬂux seen
with CD3 ligation of CD44hi MP cells correlated with reduced
p-PLCg in these cells relative to CD44lo naı¨ve cells (Fig. 2e,h).
For the mitogen-activated protein kinase pathways, weak
induction of p-ERK by CD3 ligation in CD44hi cells could not
be overcome by addition of costimulation via CD28 ligation
(Fig. 2f,g) and did not apply to p-p38 or p-JNK induction
(Supplementary Fig. 2j). For p-ERK induction, weaker induction
in CD44hi MP cells than CD44lo naı¨ve CD8þ T cells was
apparent from 5min to 2 h after CD3 stimulation. Surprisingly,
this difference was reversed at 24 h: at this time, p-ERK induction
in CD44hi MP cells rose to very high levels and was paralleled by
strong induction of p-AKT (Fig. 2j). Notably, such signalling was
abolished by mAb blockade of IL-2, indicating that the strong
induction of p-ERK and p-AKT in the cultures at 24 h reﬂected
rapid production of IL-2 by the memory cells.
TCR sensitivity of antigen-induced memory CD8þ T cells.
Since MP cells in normal mice are not necessarily the counterpart
of memory cells primed to deﬁned antigens, we examined the
TCR sensitivity of antigen-induced memory CD8þ T cells. As for
the polyclonal CD44hi cells from B6 mice used above, poor
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Figure 2 | TCR sensitivity of naı¨ve versus memory CD8þ T cells. (a) Proliferation of CFSE-labelled CD44lo naı¨ve and CD44hi memory-phenotype (MP)
B6 CD8þ T cells after incubation with Cx-aCD3 mAb. (b) ERK phosphorylation in CD44lo and CD44hi B6 CD8þ T cells after incubation with S-aCD3 or
Cx-aCD3 mAb. (c,d) Phosphorylation of ERK and ZAP70 (c) and densitometric levels (relative to b-actin; mean±s.d.) (d) in CD44lo and CD44hi B6 CD8þ
T cells after incubation with S-aCD3 mAb. (e) Phosphorylation of ERK, ZAP-70, and PLCg in CD44lo CD5lo and CD5hi and CD44hi B6 CD8þ T cells after
incubation with S-aCD3 mAb. (f,g) ERK phosphorylation in CD44lo and CD44hi B6 CD8þ Tcells after incubation with S- or Cx-aCD3±Cx-aCD28 (f) and
S-aCD3±S- or Cx-aCD28 mAbs (g). (h) Phosphorylation of ERK, ZAP-70, and PLCg in CD44lo and CD44hi CD8þ Tcells after incubation with Cx-aCD3
and -aCD28 mAbs. (i) Flow cytometry for Ca2þ ﬂux in CD44lo and CD44hi (top) or CD44lo CD5lo and CD5hi and CD44hi CD8þ T cells (bottom) gated
from Indo-1-loaded total B6 LN cells after incubation with the indicated stimuli. (j) Phosphorylation of ERK and AKT in CD44lo and CD44hi B6 CD8þ Tcells
at 2 and 24 h after incubation with Cx-aCD3 mAb±aIL-2 mAb blockade. Data are representative of three (a,b,e–j) and at least four independent
experiments (c,d). Unpaired Student’s t-test was used for the statistical analysis. *Po0.005; **Po0.0005.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms13373
4 NATURE COMMUNICATIONS | 7:13373 | DOI: 10.1038/ncomms13373 | www.nature.com/naturecommunications
p-ERK induction following short-term CD3 ligation also applied
to experimentally induced memory CD8þ T cells, namely naı¨ve
(NA) CD44lo 2C TCR Tg CD8þ T cells primed with speciﬁc
immunogenic peptide in vivo (AgMEM) and also to 2C cells
converted from naı¨ve CD44lo to memory CD44hi cells as the
result of HP in lymphopenic hosts (HPMEM) (Fig. 3a and
Supplementary Fig. 3a). Similar ﬁndings applied to OT-1 TCR Tg
CD8þ T cells; here, lower p-ERK induction in memory cells than
naı¨ve cells applied to AgMEM OT-1 cells (Fig. 3b and
Supplementary Fig 3b,c) and also to the naturally occurring
subset of CD44hi MP OT-1 cells present in unimmunized OT-I
mice (Fig. 3b and Supplementary Fig. 3b). Thus, for each type of
memory cells examined, p-ERK induction was lower than in
naı¨ve cells (Supplementary Fig. 3d).
The above data refer to TCR signalling induced by CD3
ligation. Essentially similar ﬁndings applied following contact
with speciﬁc antigenic peptide presented by APC. Thus, when
OT-1 CD8þ T cells were stimulated with APC pulsed with
ovalbumin peptide 257–264 (OVAp), p-ERK induction was lower
in AgMEM cells than in naı¨ve cells (Fig. 3c). Similar ﬁndings
applied to upregulation of the activation marker CD69, both for
strong peptide (OVAp) and weaker peptides (Q4R7, T4, Q4H7)
(Fig. 3d,e); likewise, OT-1 AgMEM cells were less sensitive to
downregulation of CD62L than naı¨ve cells, especially with weaker
peptides at early time points (30min) (Supplementary Fig. 3e).
However, in marked contrast to these early TCR signalling events,
cytokine synthesis by OT-I AgMEM cells, like B6 MP cells, was
invariably far stronger than for naı¨ve cells (Fig. 3f and
Supplementary Fig. 3f,g).
Collectively, these ﬁndings indicated that both MP and induced
memory CD8þ T cells were less sensitive to TCR ligation than
naı¨ve cells, thus paralleling the data on naı¨ve CD5hi versus CD5lo
subsets.
Cause of TCR desensitisation in memory CD8þ T cells.
CD44lo naı¨ve and CD44hi MP CD8þ T cells displayed equivalent
expression of total LCK, ZAP-70, SLP-76 and PLCg but did show
altered expression of LAT and PKCy (Fig. 4a). Thus, LAT was
highest in CD5lo naı¨ve cells, intermediate in CD5hi naı¨ve cells and
lowest in MP cells, whereas the reverse applied to levels of PKCy.
Similar ﬁndings applied to both 2C naı¨ve and memory cells, with
notable parallel increase of CBL-B, a negative regulator of TCR
signalling25 (Fig. 4b). Hence, TCR sensitivity correlated directly
with total LAT expression but inversely with CBL-B expression
(Fig. 4b,c). This ﬁnding raised the question whether the reduced
TCR sensitivity of MP cells reﬂected enhanced expression of
CBL-B. This possibility seems unlikely, however, because MP
CD8þ T cells prepared from cblb / mice did not
show improved p-ERK induction after CD3 ligation relative to
cblbþ /þ or cblbþ / cells (Fig. 4d). An obvious question is
whether memory cells show enhanced expression of CD5,
a negative regulator for TCR signalling. This appeared to be the
case for B6 MP cells as reported previously12 but, both for AgMEM
S-αCD3 (0.5 μg ml–1)
S-αCD3 (0.5 μg ml–1; 15 min)
sAPC ± OVAp
sA
PC
 o
nl
y
OT-l NA
OT-l NA
None
OT-l + sPAC ± peptide
(1 μM; 4 h)
OVAp
PMA/
IONO
– – ++
Donor 2C
B6 CD8+ OT-I CD8+
p-ERK
p-ERK
ERK
LCK
0.72 0.16 0.75 0.26 0.22
β-actin
OT
-I N
A
OT
-I A
g ME
M OT-I AgMEM
OT-I AgMEM
OT-l NA
0.08 0
0 0
0.17 0.25
39.4
4.016.71
1.95 60.2 34.6
0.57
21.6
4.14
TNF-α
IF
N
-γ
33.94.328.9
OT-I AgMEM
OT
-I M
P
B6
 NA
B6
 M
P
Na
ïve
Ag
ME
M
HP
ME
M
(15 min)
p-ERK
ERK
OVAp
OT-l
NA
OT-l
AgMEM
CD69 O
VA
p
Q4
R7 T4
Q4
H7
Q4R7 T4
0.5 h
2 h
4 h
Q4H7
OT-l + peptide-pulsed sAPC (1 μM; h)
(kDa) (kDa)
(kDa)
39 39
39
39 0.57 0.32
OVAp (0.1 μM; 10 min)
51
3939
OT-l + sAPC pulsed
with peptides (1 μM; 4 h)
80
70
60
50
40
CD
69
+
 
ce
lls
 a
fte
r s
tim
ul
at
io
n
w
ith
 p
ep
tid
es
 (%
)
30
20
10
0
*
*
*
**
a b c
d e f
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Unpaired Student’s t-test was used for the statistical analysis. *Po0.005; **Po0.0005.
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and HPMEM cells, CD5 levels were lower in these induced memory
cells than in naı¨ve cells (Supplementary Fig. 4a and see below).
We then explored the possibility that memory cells show
increased expression of other negative regulators of TCR
signalling, namely certain PTPs. In support of this idea, relative
to naı¨ve cells, CD44hi MP CD8þ T cells displayed a striking
reduction in miR-181a, a known regulator of a number of PTPs
(ref. 9), and increased mRNA expression of DUSP5, though not
several other PTPs (Supplementary Fig. 4b). At the protein level,
however, MP cells showed increased expression of SHP-1 and
SHP-2 (ref. 26) (Fig. 4e), and two recently reported negative
regulators PTPN2 (TCPTP) and PTPN22 (LYP)27,28 (Fig. 4f).
If these or other PTPs (ref. 29) accounted for the weak TCR
sensitivity of memory cells, then adding PTP inhibitors would be
expected to enhance TCR signalling. However, tests on ﬁve
different PTP inhibitors with collective speciﬁcity for a variety of
PTPs, including SHP-1, SHP-2, LYP, TCPTP, PTP1B and
HePTP, failed to cause a measurable increase in CD3-induced
p-ERK induction (Supplementary Fig. 4c). Likewise, for two
PTPs, namely TCPTP and SHP-1, lower p-ERK induction in
memory CD8þ T cells compared with naı¨ve T cells in response
to S-aCD3 applied to cells from ptpn2 / and shp1þ / mice,
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respectively (Fig. 4g,h); note that shp1 / mice were not tested
because of the T-cell developmental defect in these mice.
An important role for CD45. Despite the above negative ﬁndings
on PTP inhibitors, we turned our attention to another PTP,
namely CD45. CD45 is expressed ubiquitously on lymphoid cells
and plays a key role in regulating TCR signalling by inducing
tyrosine dephosphorylation of p56lck (LCK) Y394 (activating
motif) and also Y505 (inhibitory motif)30; in post-thymic
T cells, phosphorylation of Y394 is most important because
pY394/pY505 double-phosphorylated LCK has the same
functional kinase activity as LCK pY394 alone31. For the
following reasons, elevated expression of CD45 has emerged as
a likely explanation for the decreased TCR sensitivity of CD44hi
memory CD8þ T cells, and also of CD44lo naı¨ve CD5hi cells
versus CD5lo cells:
First, as for CD5, levels of CD45 were higher on mature CD4þ
and CD8þ SP thymocytes than on CD4þCD8þ DP precursor
cells32 (Fig. 5a), consistent with TCR tuning of thymocytes.
Second, for naı¨ve CD44lo CD8þ T cells, including cells from
TCR Tg strains, levels of CD5 correlated directly with CD45
levels, both for total CD45 levels (Fig. 5b bottom right, c) and
expression of the different isoforms of CD45 (Supplementary
Fig. 5a). Third, CD45 expression was clearly higher on memory
cells than naı¨ve cells, both for MP cells (Fig. 5b, bottom left) and
induced memory cells (Supplementary Fig. 5b,c). This difference
in CD45 levels was conﬁrmed by confocal staining (Fig. 5d) and,
notably, was in direct accord with CD45 phosphatase activity
(Fig. 5e,f and Supplementary Fig. 5d); to measure the latter, total
CD45 was immunoprecipitated by anti-CD45 Abs from CD8þ
T-cell lysates and PTP activity was then assessed in vitro with a
speciﬁc CD45 inhibitor33,34 (CD45i; N-(9,10-Dioxo-9,10-dihydro-
phenanthren-2-yl)-2,2-dimethyl-propionamide) (Supplementary
Fig. 5e,f). Fourth, signiﬁcantly, high CD45 expression and its
phosphatase activity correlated directly with reduced constitutive
levels of its major substrate p-Y394-LCK, and also p-Y505-LCK, in
memory cells (Fig. 5g,h and Supplementary Fig. 5g,h); this also
applied for CD5hi versus CD5lo B6 naı¨ve CD8þ T cells (Fig. 5i and
Supplementary Fig. 5g,h; for Fig. 5i, data are shown also for HY
naı¨ve subsets, with unseparated naı¨ve 2C and OT-I cells as a
control). Fifth, for naı¨ve CD8þ T cells, sorted cells expressing a
high density of CD45 (CD45hi), like CD5hi cells, exhibited weaker
CD3-induced TCR signalling (p-ZAP-70, p-PLCg and p-ERK)
than CD45lo cells (Fig. 5j and Supplementary Fig. 5i). Finally, and
most importantly, the above-mentioned speciﬁc inhibitor of CD45
phosphatase activity, CD45i (Fig. 5f), caused a prominent increase
in p-ERK induction following CD3 ligation (Fig. 6a); this applied to
three additional CD45-speciﬁc inhibitors (NSC95397, R164259
and S349631)35 with a similar and even more marked enhancing
effect relative to CD45i (Fig. 6b,c and Supplementary Fig. 6a,b); no
such effect was seen with a spectrum of inhibitors reactive to other
PTPs (Fig. 6b). The enhancing effect of CD45i applied to both
naı¨ve and memory CD8þ T cells (Fig. 6d) and depended on the
relative level of CD45 on the cells; thus, titration experiments
showed that the enhancing effect of CD45i was less pronounced on
CD44hi than CD44lo cells (Fig. 6e) and, for naı¨ve cells, less on
CD44lo CD5hi cells than CD44lo CD5lo cells (Supplementary
Fig. 6c) and also less on CD44lo CD45hi cells than CD44lo CD45lo
cells (Supplementary Fig. 6d). In addition to p-ERK, CD45i
enhanced p-ZAP-70 induction (Fig. 6d) and also led to an
augmented Ca2þ ﬂux (Fig. 6f).
Unlike CD3 ligation, the enhancing effect of CD45i was not
observed with stimulation via PMA and ionomycin or IL-2
(Fig. 6g and Supplementary Fig. 6e) and was abolished by adding
an inhibitor (PP2) of LCK (Fig. 6h and Supplementary Fig. 6f),
implying that CD45i selectively enhanced TCR signalling events.
When tested on B cells as a speciﬁcity control, CD45i reduced
(rather than enhanced) p-ERK induction in response to IgM
ligation, with little or no effect of adding PP2 (Supplementary
Fig. 6g). Collectively, these ﬁndings indicate that the enhancing
effects of CD45i on TCR signalling of CD8þ T cells are largely
speciﬁc and LCK dependent.
Inﬂuence of CD45 inhibition in basal TCR signalling. The
above ﬁnding that CD45 inhibition enhanced CD3-induced TCR
signalling raises the question whether steady-state levels of CD45
on resting CD8þ T cells control quiescent basal TCR signalling.
Here, it is striking that, even without CD3 ligation, adding CD45i
alone to puriﬁed B6 naı¨ve CD8þ T cells caused a rapid increase
in background expression of p-ERK and also p-LCK, p-ZAP-70
and p-LAT, though not p-CD3z, implying onset of TCR signal-
ling (Fig. 7a); likewise, CD45i caused an increase in background
Ca2þ inﬂux, especially in naı¨ve CD8þ T cells (Supplementary
Fig. 7a). The enhancing effect of CD45i on resting CD8þ T-cell
subsets was conﬁrmed by immunoblot analysis and elevated
confocal staining for p-Y394-LCK for both naı¨ve (CD5lo and
CD5hi) cells and CD44hi MP cells (Fig. 7b and Supplementary
Fig. 7b); similar ﬁndings applied for p-Y505-LCK (Fig. 7c,d,
tested on naı¨ve cells) and also p-ZAP70 (Supplementary Fig. 7c).
Importantly, as for CD3 ligation, the enhancing effect by CD45i
alone on basal TCR signalling (p-LCK, p-ZAP-70 and p-ERK)
was abolished by adding PP2 (Fig. 7c–e and Supplementary
Fig. 7c), indicating dependency on LCK.
The above enhancing effect of CD45i on basal TCR signalling
was observed in the absence of APC (though it should be noted
that CD8þ T cells themselves are MHC Iþ ). Notably, however,
with naı¨ve OT-I CD8þ T cells, the increase in background
p-ERK induced by CD45i was greatly increased by addition of
APC, with or without speciﬁc peptide (Fig. 7f). This enhancing
effect by adding APC was much less prominent with MHC-Ilo
Tap1-deﬁcient APC (Fig. 7g), implying a requirement for TCR
contact with self-pMHC ligands on APC. The implication
therefore is that basal TCR signalling driven by tonic TCR
contact with self-pMHC on APC is continuously kept in check by
CD45 PTP activity via modulation of active LCK, thereby
maintaining self-tolerance; such tolerance is broken by addition
of CD45i.
The ability of CD45 to restrain basal TCR signalling raises the
possibility that inhibiting CD45 activity on CD8þ T cells would
enhance TCR sensitivity to foreign antigens. In support of this
possibility, naı¨ve OT-I cells treated brieﬂy in vitro with CD45i
and then adoptively transferred to B6 mice showed much faster
upregulation of early activation markers, CD25 and CD69,
following OVA peptide immunization, as compared with
untreated OT-I cells (Fig. 8a,b); likewise, downregulation of
CD62L and TCRb was markedly enhanced in CD45i-treated
OT-I cells (Supplementary Fig. 8a), Similar ﬁndings applied to
IFN-g production (Fig. 8c and Supplementary Fig. 8b,c). These
data required the presence of speciﬁc peptide. Hence, although
CD45i pretreatment did not induce overt self-reactivity, such
treatment did substantially augment TCR sensitivity to a foreign
antigen.
Collectively, these ﬁndings indicate that high expression of
CD45 on peripheral CD8þ T-cell subsets in steady-state
condition is an important checkpoint for modulating their
relative TCR sensitivity, not only to self-ligands but also to
foreign antigens.
Discussion
The data in this paper shed new light on TCR tuning. As
mentioned earlier, TCR tuning is well documented during thymic
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development and is viewed as a mechanism to ﬁne-tune the TCR
sensitivity of mature post-thymic T cells. For naı¨ve T cells, these
cells have to receive TCR signals through contact with self-pMHC
ligands to survive in interphase, but such signalling has
to be relatively weak to avoid breaking self-tolerance. Although
TCR tuning is associated with upregulation of a number of
negative regulators of TCR signalling, notably CD5, the precise
mechanism of TCR tuning is still unclear. As shown here,
addressing this question depends on the particular parameters
used to measure TCR sensitivity.
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In initial experiments, we found no evidence that mature
T cells with high levels of CD5 displayed a reduction in TCR
sensitivity. In fact, by three parameters, the TCR reactivity of
CD5hi naı¨ve CD8þ T cells was actually higher than for CD5lo
cells. This applied to constitutive phosphorylation of CD3z, to
in vitro proliferation induced by CD3 ligation, and, as shown
previously12, to HP occurring in lymphopenic hosts. Moreover, as
for HP, recent studies showed that CD5hi naı¨ve T cells led to far
greater antigen-speciﬁc expansion than CD5lo cells after pathogen
infection10,13. For early TCR signalling events, however, the
results described here were totally different. Thus, as deﬁned by
induction of p-ERK, p-ZAP-70, p-PLCg, a Ca2þ ﬂux and CD69
expression soon after CD3 ligation, CD5hi cells were appreciably
less TCR sensitive than CD5lo cells. Hence, by these parameters,
CD5hi cells did display clear evidence of reduced TCR sensitivity
relative to CD5lo cells. The opposite results observed for later
(B2–3 d) proliferative responses can be attributed to differences
in sensitivity to cytokines. Thus, correlating with enhanced
expression of GM1-containing lipid rafts, CD5hi cells were more
sensitive than CD5lo cells to stimulation by endogenous IL-2
produced following CD3 ligation in vitro, and also to the raised
levels of IL-7 that drive HP in lymphopenic hosts12. The
increased background expression of p-CD3z by CD5hi cells is
less easy to explain. The possibility we favour is that the partial
phosphorylation of CD3z induced by continuous TCR interaction
with self-pMHC ligands leads to a weak form of TCR signalling
which selectively promotes sensitivity to cytokines, thereby
making CD5hi cells more sensitive to IL-7 and IL-2 than CD5lo
cells. But we envisage that such signalling is not sufﬁcient to
induce typical signs of TCR signalling such as p-ERK induction.
On this point, high constitutive p-CD3z expression on CD5hi
cells is not accompanied by measurable background expression of
p-ERK, implying a lack of downstream TCR signalling.
As for naı¨ve T cells, deﬁning the TCR sensitivity of memory
CD8þ T cells depended on the assay used. As mentioned earlier,
most, though not all, previous studies found that memory CD8þ
T cells gave more prominent proliferative responses to antigen
than naı¨ve cells. In line with this ﬁnding, as shown here, MP
CD44hi CD8þ T cells gave far stronger in vitro proliferative
responses after CD3 ligation than CD44lo cells, reﬂecting both
higher synthesis of IL-2 and higher expression of IL-2Rb (CD122)
by CD44hi cells than CD44lo cells. Likewise, the observation that
HP in lymphopenic hosts is faster and more intense for CD44hi
cells than CD44lo cells36 may reﬂect the enhanced sensitivity of
CD44hi cells to IL-7; as for IL-2, this enhanced sensitivity may in
part reﬂect the more open conﬁguration of cytokine loci in
memory T cells37. Despite these ﬁndings, early TCR signalling
events were clearly less marked in CD44hi cells than CD44lo cells.
This ﬁnding applied to induction of p-ERK, p-ZAP-70, p-PLCg,
a Ca2þ ﬂux and upregulation of CD69, and was apparent
for both MP and induced memory CD8þ T cells and
with stimulation by peptide-loaded APC as well as by CD3 or
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CD3/CD28 ligation. By these parameters, memory CD8þ T cells
showed reduced TCR sensitivity relative to naı¨ve CD8þ T cells.
It is important to emphasize that this evidence for TCR
desensitisation of memory cells applied only within the ﬁrst few
hours of stimulation and was reversed at later stages as the result
of stimulation by endogenous IL-2.
With regard to the cause of TCR desensitisation in memory
CD8þ T cells, regulation by CD5 seems unlikely because, in
contrast to MP cells, TCR transgenic AgMEM and HPMEM CD44hi
cells both showed substantially lower expression of CD5 than
naı¨ve cells. Likewise, based on studies with gene knockout mice,
we could ﬁnd no evidence that the decreased TCR sensitivity of
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ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms13373
10 NATURE COMMUNICATIONS | 7:13373 | DOI: 10.1038/ncomms13373 | www.nature.com/naturecommunications
memory CD8þ T cells reﬂected increased expression of CBL-B.
Others have described lower TCR expression on memory cells
than naı¨ve cells19. However, in our hands this difference, though
detectable, was very slight (Supplementary Fig. 5b).
For PTPs, others reported increased expression of PTPN2
(TCPTP), PTPN12 (PTP-PEST) and PTPN22 (LYP) in memory
CD8þ T cells19, which is of interest because deletion of these and
other PTPs is associated with TCR hyper-reactivity and onset of
autoimmune disease28,29,38–41. In our studies, we found increased
expression of SHP-1 and SHP-2 proteins, as well as TCPTP and
LYP proteins both in MP cells and CD5hi naı¨ve CD8þ T cells
relative to CD5lo cells. However, it is questionable whether the
elevation of these and other PTPs could account for the decreased
TCR sensitivity in these cells. If this were the case, broad-
spectrum phosphatase inhibitors would be expected to increase
TCR sensitivity. However, tests with six different phosphatase
inhibitors showed no increase in TCR signalling when the
inhibitors were added during CD3 ligation. Consistent with the
inhibitor data, we could ﬁnd no evidence for a role of TCPTP or
SHP-1 in TCR tuning of CD8þ T cells when cells lacking TCPTP
or expressing reduced levels of SHP-1 were tested. The
implication therefore is that, though important for modulating
the immune response, the above individual PTP may have only a
minor role in restraining TCR signalling of resting CD8þ T cells.
Vanadate (Na3VO4), a potent inhibitor for multiple PTPs, did
show a clear enhancing effect of p-ERK induction after CD3
ligation. However, this effect may be largely a reﬂection of
inhibition of CD45 activity (see below).
The PTP inhibitors that failed to alter TCR signalling
sensitivity included reagents with speciﬁcity for PTPN22. This
ﬁnding may seem surprising because deﬁciency of PTPN22 was
recently shown to cause enhanced TCR sensitivity to stimulation
with relatively weak antigenic peptides, though this effect was
not seen with strong peptides28. However, in our studies the
differences in TCR sensitivity between naı¨ve and memory cells
and also between CD5hi and CD5lo naı¨ve cells applied equally to
strong and weak TCR stimulation. Moreover, for naı¨ve cells,
we observed only a marginal difference in PTPN22 levels between
CD5hi and CD5lo cells despite their prominent difference in TCR
sensitivity. It should be mentioned that in other studies PTPN22
deﬁciency had little or no effect on TCR sensitivity under various
conditions38,42. Despite these ﬁndings, PTPN22-deﬁcient mice do
show a moderate increase in memory CD8þ T cells in later life,
though with no change in naı¨ve cells38. Hence it seems likely that
PTPN22 does play a signiﬁcant, though mild role in restricting
TCR sensitivity to self-ligands.
With regard to other PTPs, PTPN2 clearly deserves considera-
tion because PTPN2-deﬁcient CD8þ T cells were reported to be
more reactive than wild-type (WT) cells in response to TCR
ligation in vitro, and gave far stronger HP in lymphopenic
hosts27,41. Consistent with these data, we found that
PTPN2-deﬁcient cells showed relatively higher p-ERK induction
than WT cells after CD3 ligation. Nevertheless, the hierarchy of
TCR sensitivity reported here for CD8þ T cells (CD44lo
CD5lo4CD44lo CD5hi4CD44hi) was the same for PTPN2-
deﬁcient and WT cells. Similar ﬁndings applied for shp1þ /
versus shp1þ /þ cells. Hence, altered expression of these two
PTPs seems an unlikely explanation for the difference in TCR
sensitivity shown here for resting CD8þ T-cell subsets.
In searching for other explanations for TCR tuning of
peripheral CD8þ T cells, the possibility that CD45 could be
involved may seem unlikely because CD45 is generally viewed
as a positive regulator of TCR signalling by causing depho-
sphorylation of inhibitory p-Y505-LCK (ref. 43). However, more
recent evidence suggests that, for mature T cells, CD45 has an
overall negative effect on TCR signalling by dephosphorylating
p-Y394-LCK, which keeps LCK in an active conﬁguration.
In favour of a negative effect of CD45, several studies with
transgenic mice have shown that reducing total amounts or
relative activity of CD45 on T cells to 10–40% of normal can
cause TCR hyper-reactivity, accelerated rejection of pathogens,
and signs of autoimmunity33,44–46. Likewise, there is reciprocal
evidence that overexpression of CD45 in transgenic mice reduces
TCR reactivity47,48. The data shown here on CD8þ T-cell subsets
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from B6 mice are clearly consistent with this model. Thus, for
naı¨ve CD8þ T cells, the reduced TCR sensitivity of CD5hi cells
relative to CD5lo cells correlated directly with higher expression
of total CD45 (and the various CD45 isoforms), higher levels of
total CD45 phosphatase activity, and reduced expression of
p-Y394-LCK (and also p-Y505-LCK). Similarly, the decreased
TCR sensitivity of memory CD8þ T cells versus naı¨ve CD8þ T
cells correlated with higher CD45 levels (and also total CD45 PTP
activity) and lower p-Y394-LCK on memory cells. One apparent
discrepancy is that, in sharp contrast to CD45 transgenic mice
with intermediate levels of CD45, T cells from CD45 transgenic
mice with unphysiologically low levels of CD45 (B3–15% of
WT levels) showed reduced TCR sensitivity45,48. This ﬁnding
correlated with aberrantly high accumulation of inactive
p-Y505-LCK on the cells and may have no counterpart in
normal mice where CD45 levels are substantially higher. Thus, as
shown here in normal mice, mature T cells with the lowest
density of CD45 invariably had the highest TCR sensitivity.
Studies with CD45i provided direct support for the view that
the reduced TCR sensitivity of CD5hi naı¨ve and memory CD8þ
T cells, relative to naı¨ve CD44lo CD5lo T cells, reﬂected negative
regulation by CD45. Thus, in marked contrast to the other PTP
inhibitors tested, addition of CD45i greatly increased p-ERK and
p-ZAP-70 induction and also a Ca2þ ﬂux after CD3 ligation,
both for naı¨ve and memory CD8þ T cells. Although PTP
inhibitors are rarely if ever entirely speciﬁc for particular
substrates, multiple approaches suggested that the speciﬁcity of
CD45i was heavily skewed to CD45 with minimal activity on
other candidate modulators of TCR signalling. In particular, the
capacity of CD45i to enhance TCR signalling was observed with
three other inhibitors with known CD45-speciﬁc reactivity but
was undetectable with other PTP inhibitors. Moreover, CD45i
was highly speciﬁc for TCR/CD3-induced, LCK-dependent
signalling. Thus, the enhancing ability of CD45i was (a) abrogated
by addition of an LCK inhibitor PP2, (b) did not apply to
stimulation of T cells via PMA and ionomycin or IL-2 and (c)
also did not apply to IgM-induced stimulation of B cells (where
CD45 acts as a positive regulator for BCR signalling48).
In addition, it is notable that the enhancing effect of CD45i on
CD8þ T cells was dependent on the density of CD45 on the cells,
being more marked for cells with a low density of CD45, that is,
CD44lo naı¨ve cells sorted for low CD45 expression. Collectively,
these data validate the credentials of CD45i for inhibiting CD45
activity and thereby consolidate the view that the restraining
inﬂuence of CD45 on TCR sensitivity is most prominent
for CD8þ T cells with the highest density of CD45, namely
memory cells.
Although the capacity of high CD45 levels to limit TCR
sensitivity was shown previously for CD45 transgenic mice45,48,
the data presented here provide the ﬁrst clear evidence that levels
of CD45 on T cells are physiologically relevant and control the
relative TCR sensitivity of resting CD8þ T cells, both for naı¨ve
and memory subsets. For both subsets, CD45 levels correlated
directly with levels of p-Y394-LCK, thereby serving to modulate
proximal TCR signalling events and reduce self-reactivity. For
naı¨ve CD8þ T cells, CD45 levels correlated directly with CD5
levels. Since CD5 expression on CD8þ T cells is thought to
correlate directly with their intrinsic TCR/self-pMHC reactivity,
the implication therefore is that cells with relatively strong self-
reactivity (CD5hi CD3zhi CD45hi CD8þ T cells) are restrained
from overt self-responsiveness by their high density of CD45,
which reduces p-Y394-LCK and thereby limits TCR sensitivity. In
this respect, it is notable that addition of CD45i to puriﬁed CD8þ
T cells without CD3 ligation led to p-ERK induction and other
signs of TCR signalling, presumably through TCR contact with
self-pMHC ligands on neighbouring T cells. Moreover, much
stronger p-ERK induction occurred with addition of APC, but not
with MHC-Ilo Tap1-deﬁcient APC. Consistent with the effect of
CD45i on increasing TCR sensitivity, pretreating OT-I cells
with CD45i before adoptive transfer markedly enhanced the
early response of these cells to speciﬁc peptide. Hence, CD45i
treatment increases responsiveness to both self and foreign
antigens. In future studies it will be important to extend these
ﬁndings by examining the effects of conditionally deleting CD45
in mature T cells.
Although CD45 levels correlated closely with p-Y394-LCK
levels, precisely how CD45 controls TCR tuning is unclear.
Various factors could be important, including distribution/
localization of CD45 to lipid rafts on the T-cell membrane,
protein interaction via the CD45 cytoplasmic domain, different
ligand interaction via differential glycosylation of its extracellular
domain, and variation in dimerization by different isoforms49.
It is also unclear how the density of CD45 on mature CD8þ
T cells is controlled. For resting memory CD8þ T cells, it is
notable that survival of these cells, unlike naı¨ve cells, is MHC-I
independent, implying an absence of baseline TCR signalling in
memory cells. However, despite the apparent inverse correlation
between CD45 expression and tonic TCR signalling,
understanding this relationship will require further investigation.
In conclusion, we show here that, after positive selection in the
thymus, naı¨ve CD8þ T cells are subjected to a second step of
TCR tuning via upregulation of CD45, which reduces basal levels
of p-Y394-LCK and thereby modulates their TCR sensitivity.
CD45 upregulation is most prominent for cells with high intrinsic
self-pMHC reactivity and is tailored to enable naı¨ve cells to
receive survival signals through TCR/self-pMHC interaction
while maintaining self-tolerance, but without compromising
reactivity to foreign antigens. A further step of TCR tuning
occurs when naı¨ve CD8þ T cells respond to antigen and become
memory cells: enhanced CD45 upregulation on memory cells
mildly reduces their TCR sensitivity (and self-reactivity) but
elevated responsiveness to cytokines and possibly also other
mediators ensure that these cells display robust responses to
foreign antigens. In addition to CD45, TCR sensitivity is probably
modulated by other PTPs and/or other negative regulators on T
cells; whether the latter inhibitors act during normal T-cell
homeostasis rather than during the immune response is still
unclear.
Methods
Mice. C57BL/6 (B6) and B6.SJL (Ly5.1) mice were obtained from Australian
Bioresources Centre (ABR, Australia) and POSTECH Biotech Centre (PBC,
Korea). Sources of OT-I (Thy1.1), 2C (Ly5.1) and HY TCR Tg mice, and il2 /
and tap1 / mice, all on a B6 background, were reported12. The cblb /
homozygote and cblbþ /þ WT mice were all on a B10.BR background50 and
obtained from the same littermates by crossing cblbþ / heterozygote mice.
Lck-Cre.Ptpn2 f l/f l (ptpn2 / ; conditional deletion for PTPN2) and motheaten
viable mice (mev; null mutation for SHP-1), all on a B6 background, were used as
reported41,51. All mice were maintained under speciﬁc pathogen-free conditions
and female mice were used at 6–12 weeks of age for experiments without need of
randomization or blinding tests, according to protocols approved by the Animal
Experimental and Ethic Committee at the Garvan Institute (Australia) and the
Institute for Basic Science (Korea).
Reagents. Recombinant mouse IL-2 and IL-7 were purchased from PeproTech.
SIYRp (SIYRYYGL; speciﬁc for 2C TCR) and OVAp (SIINFEKL) and its variant
peptides (Q4R7, SIIQFERL; T4, SIITFEKL; and Q4H7, SIIQFEHL; all speciﬁc for
OT-I TCR) were purchased from Mimotopes. LCK inhibitor PP2 and various PTP
inhibitors, LYPi II, PTPi IV, PTPi XVIII, HePTPi, SHP1/2i, CD45i, NSC95397 and
vanadate (Na3VO4) were all purchased from Calbiochem and dissolved in DMSO
(Sigma-Aldrich). Two CD45-speciﬁc inhibitors, R164259 and S34963135, were
generously provided by N. Bottini (La Jolla Institute for Allergy and Immunology).
Antibodies for ﬂow cytometry. Cell suspensions were prepared and stained for
FACS analysis of cell-surface markers using PBS containing 2% FBS and 0.05%
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sodium azide with the following ﬂuorochrome-conjugated Abs to (from BD
Biosciences and eBioscience): CD4 (GK1.5 and RM4–5), CD5 (53-7.3), CD8a
(53-6.7), CD27 (LG.7F9), CD43 (1B11), CD44 (IM7), CD45RA (14.8), CD45RB
(16A), CD45RC (DNL-1.9), pan-CD45 (30-F11), CD45.1 (A20), CD62L (MEL-14),
CD69 (H1.2F3), CD90.1 (HIS51), CD122 (TM-b1), CD127 (A7R34), CD183
(CXCR3-173) and Ly6C (HK1.4). All Abs were used at a concentration of
1:300–1:500. Flow cytometry samples were run using a LSR II or FACSCanto II
(BD Biosciences) and analysed by FlowJo software (Tree Star).
T- and B-cell puriﬁcation. Pooled lymph node (LN) cells from the indicated mice
were stained with ﬂuorochrome-conjugated Abs to CD8a, CD5 and CD44, and
then sorted to obtain CD44lo CD5lo and CD44lo CD5hi naı¨ve CD8þ T cells and/or
CD44hi MP CD8þ T cells. The LN cells treated with Abs were also sorted to obtain
total CD44lo naı¨ve and CD44hi MP CD8þ T cells using a FACSAria (BD
Biosciences) and Moﬂo-XDP (Beckman Coulter). For B cell puriﬁcation, spleen
cells stained with Abs to B220 (RA3-6B2; eBioscience; 1:300) and CD19 (1D3;
eBioscience; 1:300) were sorted to obtain CD19þ B220þ mature splenic B cells.
Purity was routinely tested after cell sorting and was499%.
Generation of Ag- or HP-induced memory CD8þ T cells. Naı¨ve 2C CD8þ
T cells (Ly5.1þ ) were isolated by a negative selection using MACS with a CD8þ
T-cell isolation kit (Miltenyi Biotec) according to the manufacturer’s instructions
and transferred i.v. into irradiated (450 cGy) B6 mice (1 106 cells per mouse).
Recipient mice were either injected i.p. with SIYR peptide (10 mg) plus polyI:C
(20 mg; Sigma-Aldrich) to generate Ag-induced memory cells (AgMEM; n¼ 5) or left
unimmunized to generate HP-induced memory cells (HPMEM; n¼ 4). At 56 days
after adoptive transfer, SP and LN cells pooled from the recipient mice were ﬁrst
enriched for total CD8þ T cells by a MACS negative selection and then further
isolated to obtain memory donor 2C CD8þ T cells by FACS sorting with 499%
purity. As a control, naı¨ve CD44lo 2C CD8þ T cells were freshly isolated from LN
cells of 2C TCR Tg mice by FACS. For generating OT-I memory cells, MACS-
puriﬁed naı¨ve OT-I CD8þ T cells (Thy1.1þ ) were transferred i.v. into either
untreated (1 106 cells per mouse; n¼ 5) or irradiated B6 mice (n¼ 8). On day 1
after adoptive transfer, untreated recipient mice were immunized i.v. with OVAp
(10 mM)-pulsed B6 bone marrow-derived dendritic cells (BM-DC; 2 106 cells for
inducing AgMEM); for inducing HPMEM, irradiated recipients of naı¨ve OT-I cells
were either left untreated (n¼ 4) unless otherwise described or injected i.p. with
IL-2 (1 mg)/aIL-2 mAb (S4B6; 10mg; n¼ 4) complexes12 to enhance proliferation.
As with 2C memory cells, OT-I donor memory cells (both AgMEM and HPMEM)
were puriﬁed at46 months after adoptive transfer by FACS sorting. Naı¨ve control
CD44lo OT-I cells were freshly isolated either directly from OT-I TCR Tg mice
(n¼ 3) or from B6 recipients adoptively transferred with naı¨ve OT-I CD8þ T cells
7 days before (1 106 cells per mouse; n¼ 3).
Measuring TCR sensitivity by CD3 ligation. For polyclonal CD8þ T cells,
subsets of the indicated FACS-sorted naı¨ve (total CD44lo, CD5lo or CD5hi cells)
or memory (CD44hi) CD8þ T cells (0.5–2 106 cells) were cultured for indicated
various time points (ranging from 2min to several hours for early and late
responses, respectively) either with soluble (S) or plate-bound cross-linked (Cx)
anti (a)-CD3 mAb (145-2C11; BD Biosciences; 0.5–5 mgml 1 unless otherwise
described)±S- or Cx-aCD28 mAb (37.51; BD Biosciences; 5 mgml 1)±IL-2
(10 ngml 1). For Ag-speciﬁc CD8þ T cells, OT-I TCR Tg CD8þ T cells
(1–2 105 cells) were incubated with T-cell-depleted irradiated (2,000 cGy)
B6 splenic APC (sAPC; 0.5–1 106 cells) pre-pulsed with 0.1 mM OVAp.
TCR and BCR sensitivity with CD45 PTP inhibitor. FACS-sorted naı¨ve and
memory CD8þ T cells were preincubated for 10–30min with indicated con-
centrations of either PP2 (2–5 mM), CD45i (0.03–10 mM) or both inhibitors and
then cultured for additional 10–15min with various stimuli, including S-aCD3
mAb (0.5–2 mgml 1), PMA (50 ngml 1) plus ionomycin (500 ngml 1; Sigma-
Aldrich) or high dose IL-2 (1mgml 1). In an experiment for assessing BCR
sensitivity, FACS-puriﬁed splenic B cells were preincubated for 30min with or
without indicated inhibitors, PP2, CD45i or both, and then incubated for 10min
with goat anti-mouse IgM F(ab0)2 (10 mgml 1; Jackson ImmunoResearch
Laboratories). With addition of APC, sorted B6 or OT-I naı¨ve CD8þ T cells
pretreated with CD45i (5mM) or a control PBS containing 0.1% DMSO were either
left alone or coincubated with T-cell-depleted irradiated WC or Tap1-deﬁcient
sAPC (without CD3 mAb ligation); for some OT-I cultures with sAPC, OVAp
(0.1mM) was added as a positive control. For measuring TCR sensitivity to foreign
antigens in vivo, OT-I naı¨ve CD8þ T cells (Thy1.1) were pretreated with CD45i or
PBS containing 0.1% DMSO for 30min, washed twice, and transferred i.v. into B6
mice (1 106 cells per mouse; n¼ 3) that had been preinjected i.p. with OVAp
(5mg) plus polyI:C (10mg) 2 h before adoptive transfer. At 3 and 6 h post-transfer,
SP cells from the mice were analysed for expression of early activation markers,
CD25 and CD69, and other various markers indicated, as well as for intracellular
IFN-g production after 5 h OVAp restimulation in vitro, by ﬂow cytometry.
Other phosphatase inhibitors. In experiments investigating the effects of other
PTP inhibitors, FACS-sorted naı¨ve B6 CD8þ T cells were cultured for 10min with
S-aCD3 mAb (0.5 mgml 1) immediately after 30min preincubation with titrated
concentrations of the indicated PTP inhibitors, the speciﬁcity of the inhibitors
(o10mM IC50) according to the manufacturers being: LYPi II (TCPTP, PTP1B
and PEP/LYP), PTPi IV (SHP-2, PTP1B and PTP-e), PTPi XVIII (PTP1B, SHP-1
and YOP), HePTPi (TCPTP, PTP-SL, SHP-2, PTP1B, LYP, VHR, SHP-1, HePTP,
MKP-3 and STEP), DUSP1/6i (DUSP1 and DUSP6) and SHP-1/2i (SHP-1, SHP-2,
PTP1B and HePTP).
Western blot. Puriﬁed naı¨ve or memory CD8þ T cells cultured under the
conditions indicated were collected, washed with ice-cold PBS and lysed on ice for
15–30min in a lysis buffer (20mM Tris, pH7.5, 150mM NaCl, 1mM EDTA, 1mM
EGTA, 1% Triton X-100, 2.5mM sodium pyrophosphate, 1mM b-glyceropho-
sphate, 1mM Na3VO4, 1mM PMSF, 1 mgml 1 aprotinin and leupeptin). Cell
lysates were resolved by 4–12% bis–tris SDS–polyacrylamide gel electrophoresis
Gel (Invitrogen), transferred onto nitrocellulose membrane (Invitrogen), blocked
with 5% dry non-fat milk in Tris buffered saline (pH 7.4) containing 0.1%
Tween-20, and probed with the following Abs to (mAbs were used at 1:1000 and
purchased from Santa Cruz Biotechnology and Cell Signaling Technology unless
otherwise described): phospho (p)-LCK (Tyr394; rabbit polyclonal), LCK (3A5),
p-ZAP70 (Tyr319; 65E4), ZAP70 (IE7.2), p-LAT (Tyr191; E225; Abcam), LAT
(FL-233; rabbit polyclonal), SLP76 (H-300; rabbit polyclonal), p-PLCg (Tyr783;
rabbit polyclonal), PLCg1 (530; rabbit polyclonal), PKCy (C-18; rabbit polyclonal;
1:500), p-ERK1/2 (Thr202/Tyr204; D13.14.4E), ERK1/2 (H-72; rabbit polyclonal),
p-AKT (Ser473; 193H12), p-p38 (Thr180/Tyr182; D3F9), p-JNK (Thr183/Tyr185;
81E11), p-STAT5A/B (Tyr694/699; A11W; Millipore; 1:2,000), STAT5 (3H7),
SHP-1 (C14H6), SHP-2 (D50F2), TCPTP (PTPN2; E-11 and M-115), LYP
(PTPN22; G-3), Histone H3 (9715S; rabbit polyclonal) and b-actin (AC-15, AC-74;
Sigma-Aldrich; 1:10,000). For detecting p-CD3z (p21 form), a relevant membrane
section spanning a region between 14 and 38 kDa based on a protein size marker
was cut and probed with Ab to p-Tyrosine (4G10; Millipore) and conﬁrmed by
stripping and reprobing with mAb to CD3z (1z3A1; BD Biosciences; 1:500).
Immunoreactivity was detected by ECL detection system according to the
manufacturer’s instructions (GE Healthcare). Densitometry on the scanned blots
was performed by histogram analysis using Photoshop CS3 Imaging Software
(Adobe) for quantiﬁcation of the band intensity and normalized to the control.
Uncropped images of immunoblots are shown in Supplementary Fig. 9.
CD45 immunoprecipitation and in vitro CD45 PTP assay. Equal numbers of
FACS-puriﬁed B6 CD8þ T-cell subsets (CD44lo naı¨ve CD5lo and CD5hi cells and
CD44hi MP cells) were washed with ice-cold PBS and lysed on ice for 15–30min in
Pierce IP Lysis Buffer (Thermo Fisher Scientiﬁc) containing protease inhibitors.
Cell lysates were incubated overnight with mAbs to CD45 (I3/2.3, 3H1379 or
30-F11; all from Santa Cruz Biotechnology; 1:500–1:1,000) and, as a control, mAb
to CD5 (53-7.3; eBioscience; 1:250) and isotype mAb (rat IgG2b; eBioscience;
1:500), followed by Protein A/G PLUS-Agarose (Santa Cruz Biotechnology). For
detecting phosphatase activity in vitro, the immunoprecipitated complexes were
washed twice with IP lysis buffer and then twice with a PTP assay buffer (25mM
HEPES, 50mM NaCl, 0.05% Tween 20, 1mM dithiothreitol, pH 7.0) and were
added with 50–100 ml PTP assay buffer. An indicated series of dilution of the
immunoprecipitates was prepared and then incubated with 20 mM 6,8-diﬂuoro-4-
methylumbelliferyl phosphate (DiFMUP; Invitrogen) with or without various PTP
inhibitors (5–20 mM) at 30 C in a 96-well microtiter plate. Fluorescence (emission
450 nm and excitation 360 nm by the hydrolysed DiFMU) was measured from 30
to 60min after reaction in a ﬂuorescence-based microplate reader (Tecan Inﬁnite
F200 Pro). Background ﬂuorescence of PTP assay buffer only was subtracted for
each well.
Confocal staining. For CD45 confocal staining, FACS-puriﬁed CD44lo naı¨ve
CD5lo and CD5hi cells and CD44hi MP CD8þ T cells were placed at 0.5–1 105
cells on a poly-L-lysine-coated glass slide (Sigma-Aldrich), and allowed to adhere to
the slide for 5min at room temperature (RT). The cells were co-stained for 20min
on ice with ﬂuorescein isothiocyanate-conjugated CTB (Sigma-Aldrich; 1:200) and
Alexa Fluor 647-conjugated anti-CD45 (30-F11; Biolegend; 1:200) in PBS, washed
twice with PBS and then ﬁxed for 20min with cold 4% paraformaldehyde in PBS
without permeabilization. For confocal staining of LCK and ZAP-70, puriﬁed naı¨ve
CD8þ T cells were washed, ﬁxed for 20min with cold 4% paraformaldehyde in
PBS, permeabilized for 5min with 0.1% Triton X-100 in PBS and then blocked for
15min with 5% normal goat serum in PBS containing 1% BSA. Cells were stained
for 45min with either unconjugated (for p-LCK) or Alexa Fluor 488-conjugated
(for p-ZAP-70) primary Abs to p-Y394-LCK (Santa Cruz Biotechnology; 1:200),
p-Y505-LCK (Santa Cruz Biotechnology; 1:200), and p-Y319-ZAP-70 (BD
Bioscience; 1:200), washed, blocked, and then re-incubated for 30min with Alexa
Fluor 488-conjugated anti-rabbit (for p-Y394-LCK) or Alexa Fluor 647-conjugated
anti-mouse (for p-Y505-LCK) IgG (Invitrogen; 1:200). The ﬁnal slides were washed
with PBS and mounted in ProLong Gold Antifade Reagent (Invitrogen) and
analysed using a Zeiss LSM 700 laser scanning confocal microscope (Carl Zeiss) for
acquiring ﬂuorescence images.
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Ca2þ mobilization. Unsorted LN cells or FACS-puriﬁed CD8þ T-cell subsets
from B6 mice (n¼ 3) were labelled with 5 mM Indo-1 (Invitrogen) for 45min at
37 C followed by two washes and continued incubation at RT for staining with
ﬂuorochrome-conjugated Abs to CD8, CD5 and CD44 for additional 10min. After
a washing step, cell samples were prewarmed for 5min at 37 C and then run on a
LSRII for 4–5min before adding a stimulus to set baseline Ca2þ levels. Sample
analysis was immediately continued by TCR stimulation with addition of S-aCD3
mAb (5 mgml 1) for 3–4min, either untreated or followed by adding cross-linking
anti-hamster IgG (G94-56; BD Biosciences; 5 mgml 1) for additional 2–3min; for
the latter cross-linking, incubation continued by adding ionomycin (1 mgml 1) as
a positive control for measuring saturated Ca2þ levels. Data are presented as the
ratio of 398 nm (Indo-1 bound to Ca2þ )/482 nm (unbound Ca2þ ) in the indicated
subsets of CD8þ T cells.
Intracellular staining for ﬂow cytometry. For intracellular cytokine staining
(ICS), cells stimulated with indicated stimuli in the presence of GolgiStop (BD
Biosciences) were stained for cell-surface markers, ﬁxed and permeabilized using
Cytoﬁx/Cytoperm buffer (BD Biosciences) and then stained with ﬂuorochrome-
conjugated Abs to IFN-g (XMG1.2; eBioscience; 1:300) and TNF-a (MP6-XT22;
BD Biosciences; 1:300) using Perm/Wash buffer (BD Biosciences). The same ICS
protocol was used for analysing Bcl-2 and CD107a expression with ﬂuorochrome-
conjugated Abs to Bcl-2 (BCL/10C4; Biolegend; 1:200) and CD107a (1D4B;
eBioscience; 1:300). Intracellular staining for T-bet and Eomes expression
was performed with Foxp3 Staining Buffer Set (eBioscience) according to the
manufacturer’s instructions using ﬂuorochrome-conjugated Abs to T-bet (4B10;
1:200) and Eomes (Dan11mag; all from eBioscience; 1:200). For intracellular
staining for p-ERK, B6 SP cells treated with indicated stimuli were ﬁxed with 2%
paraformaldehyde at RT for 15min, followed by permeabilization with ice-cold
90% methanol for 20min on ice. After a washing step, cells were blocked with PBS
containing 2% FBS and incubated with ﬂuorochrome-conjugated Ab to p-ERK
(Thr202/Tyr204; D13.14.4E; Cell Signaling Technology; 1:100), followed by
repeated washes and continued incubation for 15min on ice with ﬂuorochrome-
conjugated Abs to cell-surface markers.
Cytokine ELISA. For detection of IL-2 and IFN-g secretion, culture supernatants
from cells incubated with indicated stimuli were collected and analysed by a
standard protocol using a cytokine sandwich ELISA kit for IL-2 and IFN-g
(all from BD Biosciences) according to the manufacturer’s instructions.
CFSE labelling and proliferation. FACS-puriﬁed subsets of CD8þ T cells from
mice indicated were labelled with CFSE (2mM) as described previously12 and
cultured for 2–7 days either with high doses of cytokines, IL-2 (0.1–1 mgml 1) and
IL-7 (1 mgml 1), or with Cx-aCD3 mAb (0.1–10 mgml 1); in some experiments
with the latter TCR stimulation, a mixture of mAbs to IL-2 (JES6-1A12) and
CD122 (TM-b1; 10mgml 1; all from BD Biosciences) were added to block IL-2
signalling. Cells were collected and CFSE dilutions were analysed by ﬂow
cytometry. Alternatively, proliferative responses of the indicated TCR-stimulated
CD8þ T cells were analysed by adding [3H]thymidine (1 mCi per well) and after a
6–12 h pulse, cells were collected and measured by a b-counter (TopCount
Microplate Scintillation Counter; PerkinElmer).
miRNA and mRNA analysis by qRT-PCR. RNA from FACS-puriﬁed CD44lo
naı¨ve CD5lo and CD5hi or CD44hi MP CD8þ T cells (B2–3 106 and
B0.5–1 106 cells for naı¨ve and memory subsets, respectively, isolated from
pooled B6 LN cells; n¼ 2–3 mice) was extracted by using the TRIzol reagent
(Life Technologies), followed by column puriﬁcation using the RNeasy Mini kit
(Qiagen) and reversely transcribed with the QuantiTect Reverse Transcription kit
(Qiagen) or SuperScript III Reverse transcription (Invitrogen) according to the
manufacturers’ instructions. TaqMan Gene Expression Assays in combination with
the Universal PCR Master Mix and the ABI-Prism 7,900 system (all from Applied
Biosystems) were used for quantiﬁcation of the following housekeeping genes and
the genes of interest (all ordered from inventory primers provided by Applied
Biosystems): Dusp5 (Mm01266106_m1), Dusp6 (Mm00518185_m1), Ptpn6
(Mm00469153_m1), Ptpn11 (Mm00448434_m1), Ptpn22 (Mm00501246_m1),
Gapdh (Mm99999915_g1) and Hprt (Mm01545399_m1). Target gene quantiﬁca-
tion was normalized to housekeeping gene expression and the data were calculated
as the CT of target genes normalized to the CT of housekeeping gene of each
sample. Analyses for miRNA-181a were performed by TaqMan real-time qRT-PCR
assay kit (has-miR-181a; Applied Biosystems) on the ABI-Prism 7900 system
(Applied Biosystems) and based on the manufacturer’s technical recommendation,
snoRNA202 was used as the internal control. In each set, the test sample was
expressed as relative expression.
Statistics. An unpaired two-tailed Student’s t-test was performed to test statistical
signiﬁcance. Differences in mean values were considered statistically signiﬁcant at a
P value of o0.05.
Data availability. All data which support the ﬁndings of this study are available
within the article (as ﬁgure data or Supplementary Information Files) and from the
corresponding author upon request.
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